Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.

Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a new version of the page; this reflects a minor update to the page's revision history rather than changes to study data.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a minor platform update. No changes to study content, eligibility criteria, or locations are indicated.SummaryDifference0.0%

- Check45 days agoChange DetectedThe Study Details page now shows Revision: v3.6.2, indicating a small update to the page metadata. The change does not affect the study's content or any actionable information.SummaryDifference0.0%

- Check59 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'; editorial changes include adding help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updating the Intervention/Treatment header, plus a revision note (Revision: v3.6.0).SummaryDifference0.4%

- Check66 days agoChange DetectedRevision: v3.5.5 was added, replacing Revision: v3.5.4, signaling a page/template update without modifying study details or visible information.SummaryDifference0.0%

Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.